| LDR | 00827cam a22002531 4500 | ||
| 001 | 001573911 | ||
| 003 | MiAaHDL | ||
| 005 | 20201027000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 800509s1962 dcu f000 0 eng | ||
| 010 | ⊔ | ⊔ | ‡a 62060442 |
| 019 | ⊔ | ⊔ | ‡a38531866 |
| 035 | ⊔ | ⊔ | ‡asdr-njr.991025293499704646 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990015739110106381 |
| 035 | ⊔ | ⊔ | ‡asdr-osu.b30823845 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)6298815 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)38531866 |
| 040 | ⊔ | ⊔ | ‡aDLC ‡beng ‡cCLE ‡dDLC ‡dBTCTA ‡dOCLCF ‡dOCLCQ ‡dOCLCO ‡dNJR |
| 050 | 0 | 0 | ‡aRA402.A1 ‡bU53 |
| 110 | 1 | ⊔ | ‡aUnited States. ‡bFood and Drug Administration. |
| 245 | 1 | 3 | ‡aAn introduction to regulatory drug analysis. |
| 260 | ⊔ | ⊔ | ‡a[Washington], ‡c1962. |
| 300 | ⊔ | ⊔ | ‡a40 pages ; ‡c27 cm |
| 336 | ⊔ | ⊔ | ‡atext ‡btxt ‡2rdacontent |
| 337 | ⊔ | ⊔ | ‡aunmediated ‡bn ‡2rdamedia |
| 338 | ⊔ | ⊔ | ‡avolume ‡bnc ‡2rdacarrier |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aDrug adulteration. |
| 740 | 0 | ⊔ | ‡aRegulatory drug analysis. |
| CID | ⊔ | ⊔ | ‡a001573911 |
| DAT | 0 | ⊔ | ‡a20200303192718.0 ‡b20201027000000.0 |
| DAT | 1 | ⊔ | ‡a20220509140521.0 ‡b2024-03-16T18:06:28Z |
| CAT | ⊔ | ⊔ | ‡aSDR-NJR ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-njr.991025293499704646 ‡arul ‡bSDR ‡cNJR ‡prul.39030039501301 ‡sNJR ‡1991025293499704646 |
| 974 | ⊔ | ⊔ | ‡bNJR ‡cNJR ‡d20240316 ‡sgoogle ‡urul.39030039501301 ‡y1962 ‡rpd ‡qbib ‡tUS fed doc |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230625 ‡sgoogle ‡umdp.39015004405232 ‡y1962 ‡rpd ‡qcrms |
| 974 | ⊔ | ⊔ | ‡bOU ‡cOSU ‡d20240421 ‡sgoogle ‡uosu.32435012526901 ‡y1962 ‡rpd ‡qbib ‡tUS fed doc |